Showing posts with label Brain Posts. Show all posts
Showing posts with label Brain Posts. Show all posts

Thursday, 2 June 2016

The Future of Neuroscience Education

I spent the majority of my career in medical education and saw significant changes over time.

One encouraging sign was the emergence of neuroscience as a respected and beneficial academic discipline.

Now, a new perspective on Neuroscience Training for the 21st Center has been written by Huda Akil and colleagues. This perspective is recently published in the journal Neuron with free access to the full-text manuscript.

Here are my notes from reading this perspective. Readers can access the free full-text manuscript by clicking on the link in the citation below.

Two important challenges for the field

  • Incorporating data and statistical skills traininng in neuroscience
  • Integration of other scientific disciplines in neuroscience research (engineering, CS)

Need to improve trainee skills in high-level programming languages (i.e. MATLAB)

Enhanced communication skills in training are needed to address publication and grant-writing challenges

Improvement is needed in "enabling the process by which basic science discoveries add fundamental knowledge to the field and inform solutions for disabiling neurological and psychiatric conditions". 

The above goal can be met by integrating collaborative training of basic and clinical neuroscience trainees.

Neuroscience trainees will need to be trained to meet demands of job availability
Number of neuroscience Ph.Ds graduate greatly exceed number of academic faculty slots
Federal research funding is unable to meet needs of many neuroscience graduates
However, non-academic private positions in neuroscience are expanding providing optimism for many neuroscience Ph.Ds

Key roles exist in multiple sectors to attract and train the best and brightest
  • Academia
  • Private sector
  • Societies and Patient-Advocacy Organizations
  • NIH, NSF and other funding agencies

These agencies must plan and work together to "ensure the success of this next generation of neuroscientists"

My Commentary
This is an outstanding summary of the challenges and opportunities for neuroscience education. As a physician I am particularly excited about clinical opportunities for integrating basic neuroscience training the the medical setting. I have recently been thinking about how a name change for neurology and psychiatry might aid in this evolution. Stay tuned for a provocative post on a new integrated neuroscience medicine discipline.

Follow me on Twitter WRY999

Photo of brown thrasher is from my personal file collection.

Akil, H., Balice-Gordon, R., Cardozo, D., Koroshetz, W., Posey Norris, S., Sherer, T., Sherman, S., & Thiels, E. (2016). Neuroscience Training for the 21st Century Neuron, 90 (5), 917-926 DOI: 10.1016/j.neuron.2016.05.030

Wednesday, 1 June 2016

Pain Prevalence in Dementia

The development of speech and language impairment in dementia presents barriers in many clinical domains.

One important clinical domain is assessment and management of pain. Dementia may preclude spontaneous or interview-elicited pain reporting.

A report today in MedicalXpress noted reduced reporting of pain in patients with diabetes and cognitive impairment.

I was able to locate one free full-text manuscript reviewing the prevalence of pain in various types of dementias. This literature review found the following:

  • Pain prevalence was estimated at 46% of Alzheimer's disease patients
  • Pain prevalence was estimated at 56% of vascular dementia patients
  • Pain prevalence was estimated at 53% in mixed dementia patients
  • Insufficient research study was found for determining rates of pain in frontotemporal and Lewy body dementia populations

These studies support rigorous pain assessment and monitoring for pain in dementia patient populations. Alert clinicians and nurses can aid in proxy assessment of pain when speech and language impairments reduce pain self reporting.

You can access this full text review manuscript by clicking on the PMID in the citation below.

I found a helpful education sheet produced by the Australian government on pain in dementia. This sheet included a list of potential non-verbal signs of pain in later stages of dementia including:
  • Facial grimacing
  • Moaning or crying out with movement
  • Increased heart rate, blood pressure or sweating
  • Changes in sleep patterns including increased or restless sleep
  • Changes in behavior including increased irritability or aggression.

You can access the Pain and Dementia Education in the Dementia Q&A section at this link. 

Follow the author on Twitter HERE

Photo of ring-billed gull in flight is from my files.

van Kooten J, Binnekade TT, van der Wouden JC, Stek ML, Scherder EJ, Husebø BS, Smalbrugge M, & Hertogh CM (2016). A Review of Pain Prevalence in Alzheimer's, Vascular, Frontotemporal and Lewy Body Dementias. Dementia and geriatric cognitive disorders, 41 (3-4), 220-32 PMID: 27160163

Tuesday, 31 May 2016

The Promise of DTI (Imaging) in Neurology

Brain diffusion tensor imaging (DTI) is emerging as new important brain imaging tool in research.

Clinicial applications of DTI are lagging the research applications in development.

However, clinical applications are coming.

The Radiological Society of North America recently published a summary of potential application for DTI in Neurology on their website. You can access the website post HERE.

Three key areas were highlighted in this post including use of DTI for:
  • Aiding Identification of Prognosis in Mild TBI
  • Gender Effects on Sports-Related Head Injury
  • Brain Mapping Neurosurgery

Included at the website are two You Tube Videos. Here is the video related to using DTI as a prognostic aid in TBI.




Dr. ML Lipton featured in the You Tube video has a free full-text published a study of DTI in soccer heading in the manuscript cited below. Click on the PMID to get to the manuscript.

In this manuscript the authors were able to identify change in white matter brain microstructure related to prevalence of soccer heading independent of concussion.

Image of white matter corona radiata is my screen shot from the iPad app Brain Tutor.

Follow me on Twitter WRY999

Lipton ML, Kim N, Zimmerman ME, Kim M, Stewart WF, Branch CA, & Lipton RB (2013). Soccer heading is associated with white matter microstructural and cognitive abnormalities. Radiology, 268 (3), 850-7 PMID: 23757503






Friday, 27 May 2016

Prenatal Smoking and Offspring Schizophrenia

The topic prevention of brain disorders  is commonly neglected. This is despite increasing evidence for evidence-based support for prevention opportunities.

This issue is highlighted in a recent study out of Finland that examined prenatal nicotine metabolite levels and offspring diagnosis of schizophrenia.

In this study, Solja Niemela and the Finnish research team examined all live births in Finland between 1983 and 1998.

What makes this study powerful is the measurement of maternal serum cotinine levels in maternal serum during the early and mid stages of prenancy. Cotinine is a metabolite and the levels of cotinine reflect the level of nicotine consumption.

The key findings from this study include the following points:

  • Measuring cotinine levels as a continuous variable yielded an increased odds ratio for schizophrenia of 3.41 (95% CI 1.86-6.24)
  • Mothers in the highest cotinine level group had a 38% increase in offspring schizophrenia rates
  • These findings included controlling for potential confounding variables including maternal age and parental history of psychiatric disorders

Interestingly a PubMed search found a second study linking maternal smoking with increased risk of offspring diagnosis of bipolar disorder (odds ratio 2.01, 95% CI 1.48-2.53).

These two studies in combination support a potential non-specific effect of prenatal nicotine exposure on risk for two of the most impairing psychiatric disorders. 

These two studies also support aggressive smoking cessation efforts in young women before pregnancy or at the latest very early after conception.

You can find more information about these two studies by clicking on the citation links below.

Follow the author on Twitter WRY999

Photo of pair of pin-tail ducks is from my files.

Niemelä, S., Sourander, A., Surcel, H., Hinkka-Yli-Salomäki, S., McKeague, I., Cheslack-Postava, K., & Brown, A. (2016). Prenatal Nicotine Exposure and Risk of Schizophrenia Among Offspring in a National Birth Cohort American Journal of Psychiatry DOI: 10.1176/appi.ajp.2016.15060800

Talati A, Bao Y, Kaufman J, Shen L, Schaefer CA, & Brown AS (2013). Maternal smoking during pregnancy and bipolar disorder in offspring. The American journal of psychiatry, 170 (10), 1178-85 PMID: 24084820

Wednesday, 25 May 2016

A New Chromosome Y Risk for Alzheimers

There are many risk factors for Alzheimer's Disease (AD) including history of head trauma and family history of AD.

The strongest risk factor is advanced age. Yearly risk for AD is about 1% per year in 70 year old populations jumping to around 7% in 90 year old groups.

Now a recent study is shedding some light on a new risk for AD in men. This risk appears to be related to a chromosome Y phenomenon known to be associated with aging.

Elderly men show a tendency to lose the Y chromosome from a small percentage of cells over time. This phenomenon is known as loss of Y or LOY.

The percentage of blood cells with LOY can be determined. A study recently published in Journal of Human Genetics (see citation below) found significant support for higher percentage of LOY being linked to AD risk.

Here are the key findings:

  • In a sample of 3218 elderly men 17% showed evidence of LOY chromosome mosaicism
  • LOY percentage rates were strongly positively correlated with older age
  • Men with AD had higher rates of LOY than age-matched men without AD (adjusted odds ratio=2.80)
  • Two prospective studies found higher rates of incident AD in men with LOY (adjusted odds ratio=6.80)

These findings are not simply minor as the effect of LOY on risk appears similar in magnitude to the strongest genetic risk factor for AD, APOE gene status.

LOY has also been linked to a higher risk of cancer, so it appears to be a non-specific risk factor.

The authors of this study note;
"Regardless of the underlying mechanism(s) for the increased risk of AD and cancer in men with LOY in blood, our and other's published results reinforce a role of factors on chromosome Y in various, still poorly explored biological processes, other than sex determination and sperm production."
LOY is not yet a common test in clinical practice. However, I think we will be hearing much more on this association with potential for screening and intervention studies.

Access the free full-text manuscript by clicking on the DOI link in the citation below.

Follow me on Twitter WRY999

Photo of eastern screech owl is from my photo files.

d sperm production.
Dumanski JP et al (2016). Mosiac loss of chromosome Y in blood is associated with Alzheimer's disease American Journal of Human Genetics : 10.1016/j.ajhg.2016.05.014

Tuesday, 24 May 2016

Does Flu Vaccination Reduce Dementia Risk?

In my daily review of neuroscience news I ran across an article flu vaccination and dementia risk in heart failure.

This study was reported at the 3rd World Congress on Acute Heart Failure by Dr. Ju-Chi Liu from Taipei Medical University.

So how might influenza vaccination be related to dementia risk?  We do know acute influenza infection reaches the brain causing headache and increasing brain inflammation, at least temporarily. We also know brain inflammation may be involved in the mechanism of amyloid and tau protein deposition in the brain. So this link has some potential biological plausibility.

In the Taiwanese study, 20,509 subjects with a diagnosis of heart failure were followed via centralized records. About half received flu vaccination during follow up. Subjects receiving at least one flu vaccination had a 35% lower rate of dementia diagnosis compared to those not receiving any vaccination. Subjects receiving three or more vaccinations had a 55% lower risk of recorded dementia diagnosis on follow up.

I went to PubMed looking for more research for this association and a similar finding has been published by the same research group in a free full-text manuscript in patients with chronic kidney disease (CKD). The key elements of this study were:

  • Subjects: All 32,844 individuals with a chronic kidney disease diagnosis in the Taiwan National Health Insurance Research Database. From this set 11,843 subjects had sufficient data for the study.
  • Case definition: Influenza vaccination during the study period
  • Outcome definition: Research database definition of dementia during follow up period
  • Results: After controlling for confounding variables, influenza vaccination case subjects had a 36% lower rate of dementia diagnosis compared to those not vaccinated (odds ratio=.64)

Interestingly, there appeared to be a dose dependent effect with those receiving multiple influenza vaccinations showing even lower rates of dementia.

Also, somewhat unexpectedly, vaccinations given outside of the typical influenza season showed a greater effect.

The authors note in their discussion:
"In clinical practice, we suggest that CKD patients with high dementia risk be vaccinated."
The authors note dementia risk is increased in CKD with hypertension, high blood cholesterol and diabetes.

The most important potential implication in these two studies, is whether influenza might reduce dementia risk in the general non-medically ill population. I think we will have more research on this issue soon.

There are many reasons for regular influenza vaccination. Preserving brain health may be another important reason for expanded vaccination efforts.

You can access the free full-text manuscript of the CKD and dementia paper by clicking on the PMID link in the citation below.

Follow me on Twitter WRY999

Figure of influenza virus in post is from Wikipedia Creative Commons file authored by: National Institutes of Health; originally uploaded to en.wikipedia by TimVickers (), transferred to Commons by Quadell using CommonsHelper

Liu JC, Hsu YP, Kao PF, Hao WR, Liu SH, Lin CF, Sung LC, & Wu SY (2016). Influenza Vaccination Reduces Dementia Risk in Chronic Kidney Disease Patients: A Population-Based Cohort Study. Medicine, 95 (9) PMID: 26945371

Monday, 11 July 2011

Cannabis Use Declines with Aerobic Exercise

Improvement in addiction treatment interventions in needed.  Many substance dependence individuals end up with with a chronic illness with frequent relapse following periods of abstinence.

Aerobic exercise appears to be a candidate for a treatment component in a variety of addictive disorders.  Aerobic exercise may produce a variety of changes in the brain that may influence craving and drug use.

Mechanisms induced by aerobic exercise that might influence drug craving and drug use include:

  • Alteration in the brain reward circuit
  • Increased release of brain dopamine and changes in dopamine receptor sensitivity
  • Decrease in anxiety and depressive symptoms 
Maciej Bukowski and colleagues at Vanderbilt University recently published a trial of cannabis craving and use in a series of subjects.  Regular cannabis user were enrolled in a ten session intervention that included ten 30 minute supervised treadmill periods.  Subjects exercised at 60% of their calculated maximum heart rate. 

All subjects met DSM-IV criteria for cannabis dependence.  Subjects were not involved in any formal substance abuse treatment program and did not express a desire to reduce or discontinue their cannabis use.  Subjects were using an average of 33.5 standard joint equivalents of cannabis at the beginning of the study.  The average daily cannabis use of the subjects is displayed in the plot below taken from the manuscript:



The plot demonstrates a significant reduction in daily cannabis use during the active aerobic exercise period. Daily joint use dropped from approximately six joints per day to an average of about two to three joints per day during the exercise period.  Following completion of the exercise phase, daily joint use climbed up again approaching the run-period levels.

This study was not done in a treatment-seeking sample.  It is unclear whether a similar effect would be seen in treatment seeking samples.  The study did not include a control sample.  Nevertheless, this study should stimulate research in treatment samples.  It suggests that regular aerobic exercise may be a valuable component of treatment for cannabis dependence.  Extended aerobic exercise may be valuable in the longer term reduction of cannabis use in those with cannabis dependence.

Chemical model of tetrahydrocannabinol (the psychoactive substance in cannabis) from the Creative Commons file at Wikipedia authored by Ben Mills.

Cannabis use Creative Commons Attribution License plot from Plos One manuscript authored by Maciej Bukowski and colleagues referenced below.

Buchowski MS, Meade NN, Charboneau E, Park S, Dietrich MS, Cowan RL, & Martin PR (2011). Aerobic exercise training reduces cannabis craving and use in non-treatment seeking cannabis-dependent adults. PloS one, 6 (3) PMID: 21408154

Thursday, 7 July 2011

More Time In Bed Boosts Basketball Performance

Looking for that extra edge on the basketball court?  Want to increase your free throw percentage and gain an extra step in quickness?  Is it a new performance enhancing drug or training technique?  No, a new study suggests it may be as easy as spending a few extra hours in bed.

Cheri Mah and colleagues from Stanford University and the University of California, San Francisco recently published their research on sleep and athletic performance in the journal Sleep.  They introduce the study by noting that extensive research documents the adverse effect of limited sleep.  However, little research examines the effect of increased sleep on performance.  Their study objective was to do just that.

Members of the Stanford University mens basketball team were recruited for the study.  The study took place over two seasons and included a baseline period of usual sleep patterns.  Then the intervention group extended their sleep pattern with a goal of a minimum of 10 hours in bed daily.

Compliance with this intervention was measured through sleep journals and actigraphy.  Actigraphy is accomplished by a wrist device that is worn and measures movement.  From this data the total sleep time can be estimated.  Sleep journal data and activity data estimated the increase in total daily sleep time to be between 100 and 150 minutes of additional sleep during the intervention period.

Athletes in the intervention groups were tested on a variety of psychometric and basketball performance skills during the baseline and intervention period.  The results of the intervention were pretty impressive.  Here is a summary of the improvement noted in the study:

  • Free throw percentage increased by 11%
  • Three point percentage increased by 14%
  • Sprint test time decreased by 4%

Other psychometric variables were improved including a reduction in time on the Psychomotor Vigilance Task, a reduction in the Epworth Sleepiness Scale score and improvement on multiple components of the Profile of Mood States including ratings of fatigue, depression and tension.

The authors note the study has some significant limitations in research design.  Only eleven athletes received the intervention.  Subjects were not blinded as to the intervention and it is possible a some of the improvement came from an expectancy effect.  Travel schedules made it difficult to assure compliance with the 10 hours in bed intervention for every day of the study.

However, this study does suggest that many athletes may be performing in the context of ongoing sleep deprivation.  Forcing compliance with an extended sleep duration holds promise of improving performance on the basketball court.  This effect appears to occur in the context of subjective improvement in psychological function.

If I were an NCAA basketball athlete, I would send a copy of this study to my coach and training staff.  Athletes now have some research to support the importance of getting plenty of sleep to achieve peak performance.

Photo of Los Angeles Clipper Player Blake Griffin Shooting Free Throw Courtesy of Tim Yates

Mah CD, Mah KE, Kezirian EJ, & Dement WC (2011). The Effects of Sleep Extension on the Athletic Performance of Collegiate Basketball Players. Sleep, 34 (7), 943-950 PMID: 21731144

Thursday, 30 June 2011

Brain Posts Cracks Technorati Top Ten: Thanks!

I try to minimize self-promotion on this blog but today I'm going to do a little of that.  I started this blog nearly two years ago for personal motivation to stay current with research in the clinical neurosciences.  Blogging about recent research in clinical neuroscience kept me scanning PubMed abstracts directed to my Google Reader and kept me focused on succinctly summarizing work I felt was important.  Additionally, as I approach the end of my career, I felt a non-commercial blog might be a way give something back to my profession that has given so much to me.

Like many bloggers I follow my page views to see topics that might track more than typical interest.  I follow some of the blog ranking sites to gain perspective on Brain Posts.  This last week I was pleased to see that the Technorati algorithm ranked Brain Posts as the tenth ranked blog in the Family category and 40th in the Health category.  Technorati follows over 14,000 blogs in the Family category and over 15,000 blogs in the Health category.  I am very humbled and flattered by this recognition.


I don't understand the ranking algorithms (or their validity).  The numbers seem to jump around quickly and frequently.  But I do know that followers accessing the site and referencing the site play a key role in the rankings.  So this is really a post to thank those of you who have been visitors, commenters and post links to the site.

I plan to continue posting on clinical neuroscience research topics over the next year.  Additionally, I will be putting together some of the posts into electronic book formats.  This will involve selecting posts that might be of interest to specific reader groups.  Look for compilations of Brain Posts into eBooks formats under some of the following titles:

  • Brain Science for Physicians
  • Brain Science for Parents
  • Brain Science for Teachers

Thanks again to all!

Tuesday, 28 June 2011

Persistent Insomnia in Depression Responding to Antidepressants

Sleep problems commonly occur as part of a problem with mood disorders including depression.  Changes in sleep duration (insomnia or hypersomnia) are one of the criteria for the diagnosis of depression in the Diagnostic and Statistical Manual of Mental Disorders.  Although not absolutely required for the diagnosis, insomnia is a complaint in the the majority of subjects presenting for clinical trials in the treatment of depression.

The selective serotonin reuptake inhibitors (SSRIs) like fluoxetine (Prozac) have become one recommended strategy in the treatment of depression.  However, unlike other antidepressants, the SSRIs commonly do not have a sedative effect.  It is possible that when someone gets an antidepressant response to an SSRI, sleep disturbance also resolves.  However, in clinical practice, SSRIs commonly produce a partial remission of depression but fail to improve problems with insomnia.  So what does this type of response mean and what can be done for those with improvement in depression but residual sleep complaints.

Gulec and his research team from Turkey have some recent research on this topic posted online at the Journal of Affective Disorders.  They followed a group of adults with major depression treated naturalistically--i.e. treating psychiatrists could select the antidepressant drug although algorithms for dose and sequencing were followed.  Subjects were followed with research rating scales for a period of 52 weeks.  Some subjects responded and remained well.  Some subjects responded but had a recurrence of depression in the one year follow up period.  The key findings from the study:
  • Persistent insomnia rates were high in those who had a recurrence of depression
  • The recurrent groups showed the following rates of insomnia prior to recurrence: onset insomnia (difficult falling asleep) 58%, terminal insomnia (early morning awakening) 33% and middle of the night insomnia 8%.
  • Only 26% of those subjects whose depression remained remitted throughout the 52 week follow up period endorsed any persistent insomnia complaint.
The authors note their study is consistent with other studies supporting insomnia as a marker for poor prognosis is depression.  Reynolds and colleagues found that subjects who remitted with an antidepressant drug (including improvement in subjective sleep) had had high rate of continued remission of depression with psychotherapy alone.  Those whose insomnia persisted were less likely to benefit from psychotherapy alone as a long term maintenance strategy.


So an important question is what to do when insomnia persists despite a general antidepressant response.  It appears this is a problem that is too important to ignore and hope it goes away.  Options appear to include adding a sedative antidepressant, switching to another antidepressant, adding a sedative hypnotic treatment for insomnia or adding cognitive behavioral treatment for insomnia.  Here there is little data to support one of these choices over the others.  A research study examining these types of options is needed to aid patients and their clinicians in the management of this common clinical situation.


Photo of Moth Hovering Over Flower Courtesy of Tim Yates

Gulec M, Selvi Y, Boysan M, Aydin A, Besiroglu L, & Agargun MY (2011). Ongoing or re-emerging subjective insomnia symptoms after full/partial remission or recovery of major depressive disorder mainly with the selective serotonin reuptake inhibitors and risk of relapse or recurrence: A 52-week follow-up study. Journal of affective disorders PMID: 21684011

Reynolds CF 3rd, Frank E, Houck PR, Mazumdar S, Dew MA, Cornes C, Buysse DJ, Begley A, & Kupfer DJ (1997). Which elderly patients with remitted depression remain well with continued interpersonal psychotherapy after discontinuation of antidepressant medication? The American journal of psychiatry, 154 (7), 958-62 PMID: 9210746



Thursday, 23 June 2011

Brain Basis for Emotion Recognition Deficits in Depression

There is a emerging understanding of the role of social perception problems in depression and anxiety disorders.  Depression appears to effect the cognitive ability to judge the facial expression of others.  This impairment poses a challenge for interpersonal function and social relationships.  Research is now pinning down the neural basis for this deficit and to determine it’s persistence and the effect of depression remission on this social cognition function.
van Wingen and colleagues from the Netherlands recently published an fMRI study on this topic in Psychological Medicine.  The study had the following elements in research design:
  • Subjects: Twenty case subjects with first episode of major depression (medication naive), Twenty one case subjects recovered from a first episode of depression and 30 healthy individuals without a history of depression
  • f MRI Task: Visual recognition of anger or fearful face by semantic labelling or visual matching compared to a control task of matching facial orientation without attention to emotion
  • Additional Neuropsychological Testing: Depression symptom level, anxiety (state and trait) symptom level, IQ, memory, visual learning, attention, psychomotor speed and executive function.
The depression case subjects were not different from recovered depressed subjects and controls on most of the tests of neuropsychological function.  As expected, they did have higher depression symptom severity scores (Hamilton Depression Scale average for the depressed group was 21.8) and higher anxiety symptom severity scores.
The depressed group performed as well as the remitted group on the control task and the visual emotion matching task.  However, they performed worse than both groups on the semantic matching task, i.e. selecting the correct word label for the emotion displayed visually.  

The brain regions that correlated (increased activation) with impaired semantic emotion labeling included three distinct regions:
  • right amygdala
  • left inferior frontal gyrus
  • anterior cingulate cortex
The authors propose that one explanation for this finding in three distinct brain regions.

“The left inferior frontal gyrus is thought to integrate language with other information (Hagoort, 2005;Willems et al. 2007). Therefore, we suggest that the inferior frontal gyrus may integrate the semantic knowledge about the concepts of anger and fear with the emotional information conveyed by the faces by interacting with the amygdala. The concurrent activation of these systems may subsequently trigger automatic negative thoughts and stimulate task unrelated processes such as rumination (Siegle et al. 2002; Ray et al. 2005), and thereby hinder task appropriate behaviour.”

This explanation fits with the cognitive behavioral theory of depression.  The core concept being that depression is characterized by increased automatic negative thoughts about the self, the future and the environment.  The thoughts are generated by a maladaptive negative cognitive schema.  Activation of these automatic thoughts (i.e. by being shown negative facial emotions) produces distraction from tasks (i.e. correctly labelling these facial emotions). This process appears limited to when depression is present as the recovered depression group showed no deficit.

The authors also conclude the findings could be due to a compensatory mechanism for inadequate behavior or an altered coping mechanism for dealing with demanding situations. 

This study provides additional support that fMRI research may lead to advances in the treatment of depression by both psychotherapy and psychopharmacologic interventions.

Screen shot of 3D Brain showing the limbic system structures amygdala and cingulate cortex (along with the inferior frontal cortex) thought to be involved in impaired facial recogniton in depression.

van Wingen, G., van Eijndhoven, P., Tendolkar, I., Buitelaar, J., Verkes, R., & Fernández, G. (2010). Neural basis of emotion recognition deficits in first-episode major depression Psychological Medicine, 41 (07), 1397-1405 DOI: 10.1017/S0033291710002084

Monday, 13 June 2011

One Hundred Years Ago Today (June 13, 1911)

One hundred years ago today the United States was still three years away from the first of the world wars that would shape the nation forever.  In 1911, now 135 years old, the U.S. faced many challenges and opportunities.  

Looking back at 1911, U.S. historians would rank some of the most  important facts about 1911:
  • U.S. unemployment was 7.6%
  • A first class stamp was two cents
  • Princeton University won the NCAA football championship (shared with Penn State University)
  • British Physicist Edward Rutherford discovered the structure of the atom
  • American Geneticist Thomas Morgan shows that inherited traits are related to genes located at specific sites along the chromosome

In the midwestern U.S., the state of Nebraska was only 44 years old after being granted statehood in 1867.  One extended family had already been settled in the state for nearly thirty years.  Attracted to the state by the U.S. Homestead Act signed into law by President Abraham Lincoln, this family migrated to Nebraska seeking opportunity and a better life.  The Homestead Act promised inexpensive land to those who settled on the land for five years, built a home and began raising crops.

What seemed a great opportunity, came with significant hardship.  Most of the best farm land was owned by the railroad companies.  Only the marginal farm land was open to the new settlers coming to the region.  Growing crops was not easy and the Nebraska winters were cold, the summers hot and often so dry that no crops were harvested.  Most of these Homestead Act immigrants found the challenge too difficult and they moved on.

But one family living near the Fillmore County town of Geneva, persisted and did not give up.  Maybe they were too stubborn to seek other opportunities.  But persist they did and this family planted, harvested, and had children. On this day 100 years ago today (6/13/1911) into this extended family was born a son named Theodore Robert.

Probably named after U.S. president (1901-1909) Theodore Roosevelt, Theodore Robert (Bob) grew up in a difficult time.  As a child, the challenges of World War I made all Americans sacrifice.  As a young man, growing up during the Great Depression made finding a job difficult.  But despite the challenges Bob fell in love and married a young women named Florence.  With limited opportunities in Nebraska, Bob, his young wife and their infant daughter Shirley moved to California. 

Bob was later urged by his Nebraska family to return and be the principal farmer of the Yates homestead farm.  He agreed and returned to Nebraska despite a growing income and opportunity in the California citrus industry.

Back in Nebraska, he farmed the land, raised award-winning corn and started a successful beef cattle business.  He and Florence had a second child named William Robert.  

That second child born to Bob and Florence was me, William Robert Yates.  I am so fortunate to be the son of a such a kind and hard working man as Bob Yates.  I am fortunate to have had a father who cherished his family and his faith.  I am proud of my parents and the Yates family that took on the challenge to move to Nebraska and then flourished through difficult times.

Today, Brain Posts takes a break from commentary on clinical neuroscience research. Today is a day I remember my father (pictured above) born 100 years ago today.  Dad, Shirley and I love you so very much.  Although you have been gone for over 40 years, the Yates family lives on and we all strive to live up to the example of your life.

Photo above of Bob Yates watching as his corn wins highest yield competition courtesy of Yates Photography.  Photo below of me and my parents Bob and Florence Yates also courtesy of Yates Photography.  

Source for historical information on 1911 from Wikipedia. 

Wednesday, 8 June 2011

Age-Specific Psychotic Effects with Cannabis Use

There is increasing evidence that some users of cannabis may be vulnerable to adverse cognitive effects including psychotic symptoms. Many adult casual users of cannabis appear to have minimal cognitive effects. However, younger users and those with underlying mood or psychotic disorders may experience significant adverse consequences of regular and heavy cannabis abuse. A previous post linking cannabis-related psychosis to family history of psychosis is posted here.

Schubart and colleagues in the Netherlands and UCLA recently analyzed the rates of reporting psychotic experiences in European (primarily Dutch-speaking)adolescents and young adults. They looked specifically for the rates of endorsement of psychotic and mood symptoms in adolescents grouped by frequency and quantity of cannabis use.
Psychotic symptom experience is commonly grouped into what are known as positive symptoms or negative symptoms. Positive symptoms of psychosis typically include delusions, auditory hallucinations and visual hallucinations. Negative symptoms of psychosis typically include loss of motivation, withdrawal, and lack of goal directed productivity.

Over 17,000 young adults participated in the survey with over two thirds of the respondents being classified as users. Looking at the entire group of regular cannabis users, their scores on measures of psychosis and depressive symptoms did not differ from those who reported not using cannabis.

However, two factors among the users identified subgroups with signficant endorsement of symptoms of psychopathology:

  • Cannabis users who initiated use before the age of 12 were three times more likely than non-users to be in the top 10% of scores on psychotic positive symptoms
  • Regular heavy cannabis users (greater than 25 euros spent per week on cannabis) were 2.8 to 3.4 times more likely to be in the top 10% of scorers on scales of positive and negative psychotic symptoms as well as depressive symptoms.
The authors noted in the discussion that this cross-sectional design can not prove a causal pathway. It is possible that young people with psychotic symptoms may be more likely to begin using cannabis. Additionally, they note that young age of onset of cannabis use may also indicate a larger cumulative exposure that could be related to psychotic and mood symptoms.

However, they do note their findings are consistent with the possibility that tetrahydrocannabinol (or other cannabis drugs)may have increased toxicity "during critical phases of brain maturation". There may be a window of vulnerability to the effcts of cannabis. Use after passing through this window, limited cannabis use may have limited cognitive effect. Early cannabis use and heavy chronic use may be a much different story. 

Photo of a black and yellow argiope spider from North Palm Beach Florida courtesy of Yates Photography.

Schubart CD, van Gastel WA, Breetvelt EJ, Beetz SL, Ophoff RA, Sommer IE, Kahn RS, & Boks MP (2010). Cannabis use at a young age is associated with psychotic experiences. Psychological medicine, 1-10 PMID: 20925969

Thursday, 2 June 2011

Bupropion Fails to Aid Hospitalized Smokers with Heart Disease

Smoking and nicotine dependence increase rates for heart disease in the general population. Among those with heart disease, continued smoking increases mortality rates. Targeting smoking cessation efforts at those with heart disease (secondary prevention)is an important clinical challenge.
 
Most of the research data related to drugs for smoking cessation come from subjects recruited from the general population. Both bupropion (Zyban)and varenicline (Chantix)are FDA-approved drugs for smoking cessation in the United States. There is limited data of the safety and effectiveness of these two compounds in those with heart disease.

Dr. David Planer and colleagues from Israel recently published a randomized clinical trial of smokers admitted to the hospital with acute coronary syndrome (myocardial infarction or unstable angina). Subjects in this study were required to have the intent to stop smoking. Subjects received either placebo or bupropion sustained release 300 mg daily. All subjects also received five sessions of smoking cessation counseling from a nurse or physician. These counselors had some previous experience in smoking cessation and received additional training from a smoking cessation counselor prior to the trial.

Unexpectedly, bupropion failed to provide an additional increase in abstinece compared to placebo with the following rates noted at several study time points (Bupropion Bold followed by (Placebo) rates:
  • 3 months: 44% (43%)
  • 6 months: 37% (42%)
  • 12 months: 31% (33%) 
What is striking about these outcome comparisons in the rate of placebo response. The authors note nicotine dependence has one of the lowest rates of placebo response with studies commonly reporting placebo response rates as low as 10% at one year. It is possible that the effect of physician or nurse directed counseling at the time of hospitalization (when motivation may be highest)is quite powerful. This may be the most important finding from the study and provide impetus for more wide spread adoption of this strategy in clinical settings.

Interestingly, one predictor of smoking cessation at one year in this study was undergoing a cardiac procedure (angiography or coronary artery bypass graft) during the hospitalization (odds ratio 4.2, p value=.02). The authors hypothesize that undergoing an invasive procedure may potentiate the psychological distress of the hospitalization and increase motivation for smoking cessation to limit the risk of future procedures and hospitalizations. Previous outcome studies in alcoholism have found that a serious medical problem related to drinking (and the need to be abstinent to address this medical problem) is one of the strongest predictors of alcohol abstinence.

I think this study can not be interpreted to mean there is no place for bupropion in smoking cessation in those hospitalized with coronary artery disease. Coronary artery disease patients hospitalized in facilities with smoking cessation counseling resources may be better off with initiaion of bupropion or another smoking cessation drug. The study did find bupropion to be safe and generally well tolerated in this population. Bupropion might be a reasonable choice for smokers who experience depression in the course of the heart disease.

Physicians should see this study as an example of the power of their words and efforts in smoking cessation. Strongly urging smoking cessation in a place and time where it is most likely to be effective is crucial. Missing such opportunities may contribute to continued progression of heart disease and other smoking-related medical problems.

Photo of Cattle Egret from Maui Hawaii Courtesy of Yates Photography
Planer, D., Lev, I., Elitzur, Y., Sharon, N., Ouzan, E., Pugatsch, T., Chasid, M., Rom, M., & Lotan, C. (2011). Bupropion for Smoking Cessation in Patients With Acute Coronary Syndrome Archives of Internal Medicine DOI: 10.1001/archinternmed.2011.72